Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

6.5K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.5K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

5.8K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
5.8K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

7.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
7.0K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

2.3K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

642
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

785
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
785

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanoparticle-mediated delivery of tetrahydrobiopterin restores endothelial function in diabetic rats.

Nitric oxide : biology and chemistry·2024
Same author

Dietary supplementation with L-leucine reduces nitric oxide synthesis by endothelial cells of rats.

Experimental biology and medicine (Maywood, N.J.)·2023
Same author

The Tissue Response to Hypoxia: How Therapeutic Carbon Dioxide Moves the Response toward Homeostasis and Away from Instability.

International journal of molecular sciences·2023
Same author

Dietary supplementation with L-arginine between days 14 and 25 of gestation enhances NO and polyamine syntheses and the expression of angiogenic proteins in porcine placentae.

Amino acids·2021
Same author

Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.

Advances in experimental medicine and biology·2021
Same author

Dietary Intakes of Amino Acids and Other Nutrients by Adult Humans.

Advances in experimental medicine and biology·2021

Related Experiment Video

Updated: Apr 19, 2026

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
05:45

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Published on: October 25, 2019

6.5K

L-Leucine and NO-mediated cardiovascular function.

Ying Yang1, Zhenlong Wu, Cynthia J Meininger

  • 1State Key Laboratory of Animal Nutrition, College of Animal Science and Technology, China Agricultural University, Beijing, 100193, People's Republic of China, cauvet@163.com.

Amino Acids
|January 2, 2015
PubMed
Summary

High L-leucine levels contribute to insulin resistance and cardiovascular disease by reducing nitric oxide (NO) synthesis. Lowering L-leucine or inhibiting GFAT may offer novel therapeutic strategies for these conditions.

More Related Videos

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

2.2K
Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

10.6K

Related Experiment Videos

Last Updated: Apr 19, 2026

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
05:45

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Published on: October 25, 2019

6.5K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

2.2K
Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

10.6K

Area of Science:

  • Biochemistry
  • Physiology
  • Cardiovascular Medicine

Background:

  • Reduced vascular nitric oxide (NO) availability impairs insulin action, contributing to insulin resistance in obesity and diabetes.
  • Vascular insulin resistance is a key factor in the development of cardiovascular disease, a leading cause of mortality.
  • Elevated plasma L-leucine concentrations are observed in obese individuals with vascular dysfunction.

Purpose of the Study:

  • To investigate the role of L-leucine in endothelial NO synthesis and its implications for vascular insulin resistance.
  • To explore L-leucine's mechanism of action involving glutamine:fructose-6-phosphate aminotransferase (GFAT) and the mammalian target of rapamycin (mTOR) signaling pathway.
  • To propose novel therapeutic strategies targeting L-leucine levels or GFAT activity for cardiovascular disease prevention and treatment.

Main Methods:

  • Review of existing literature on L-leucine, NO synthesis, GFAT, and insulin resistance.
  • Analysis of L-leucine's unique inhibitory effect on NO synthesis in endothelial cells.
  • Examination of L-leucine's activation of GFAT via the mTOR pathway, impacting protein synthesis and NO production.

Main Results:

  • L-leucine uniquely inhibits NO synthesis from L-arginine in endothelial cells.
  • L-leucine activates GFAT, a rate-limiting enzyme in glucosamine synthesis, which inhibits endothelial NO synthesis.
  • L-leucine stimulates the mTOR pathway, potentially increasing GFAT protein expression and further reducing NO synthesis.

Conclusions:

  • Reducing circulating L-leucine levels or inhibiting endothelial GFAT activity presents a novel strategy for managing cardiovascular disease in obese and diabetic individuals.
  • Dietary supplementation with α-ketoglutarate or N-ethyl-L-glutamine may offer therapeutic benefits by modulating L-leucine metabolism or GFAT activity.
  • Interventions to prevent leucine-induced GFAT activation could enhance vascular NO synthesis and improve cardiovascular function.